Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 251
Filtrar
1.
Medicine (Baltimore) ; 99(17): e19874, 2020 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-32332655

RESUMO

INTRODUCTION: Heart transplantation (HT) is known to be the final therapy for patients with advanced heart failure; however, the exercise capacity of these patients remains under the aged-predicted value after HT. Many studies have described the effectiveness and safety of cardiac rehabilitation (CR) in HT recipients. Nevertheless, long-term follow-up data of HT recipients undergoing CR are insufficient, and there is a lack of evidence on the long-term effects of CR. In this case report, we present the long-term benefits of CR in an HT recipient, including serial follow-up clinical data over 1 year. PATIENT CONCERNS: A 48-year-old female patient underwent HT because of advanced dilated cardiomyopathy. DIAGNOSIS: Cardiopulmonary exercise test showed reduced exercise capacity and pulmonary function. The grip power and quadriceps muscle strength were also decreased after HT. INTERVENTIONS: The patient underwent a phase I CR program for 3 months, followed by a phase III CR program for 7 months. In the beginning, moderate-intensity continuous training was conducted. Thereafter, high-intensity interval training was implemented after a period of adjustment for interval training. OUTCOMES: The exercise capacity, 6-min walk distance, muscle strength, and vital capacity were improved after CR. CONCLUSION: CR in HT recipients may improve muscle strength and pulmonary function as well as exercise capacity, without serious cardiovascular complications. Phase III CR may help maintain exercise capacity in these patients.


Assuntos
Assistência ao Convalescente/métodos , Reabilitação Cardíaca/normas , Transplante de Coração/reabilitação , Resultado do Tratamento , Reabilitação Cardíaca/métodos , Reabilitação Cardíaca/tendências , Cardiomiopatia Dilatada/complicações , Cardiomiopatia Dilatada/fisiopatologia , Cardiomiopatia Dilatada/cirurgia , Terapia por Exercício/métodos , Tolerância ao Exercício , Feminino , Transplante de Coração/psicologia , Transplante de Coração/normas , Humanos , Pessoa de Meia-Idade
2.
Can J Cardiol ; 36(3): 335-356, 2020 03.
Artigo em Inglês | MEDLINE | ID: mdl-32145863

RESUMO

Significant practice-changing developments have occurred in the care of heart transplantation candidates and recipients over the past decade. This Canadian Cardiovascular Society/Canadian Cardiac Transplant Network Position Statement provides evidence-based, expert panel recommendations with values and preferences, and practical tips on: (1) patient selection criteria; (2) selected patient populations; and (3) post transplantation surveillance. The recommendations were developed through systematic review of the literature and using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system. The evolving areas of importance addressed include transplant recipient age, frailty assessment, pulmonary hypertension evaluation, cannabis use, combined heart and other solid organ transplantation, adult congenital heart disease, cardiac amyloidosis, high sensitization, and post-transplantation management of antibodies to human leukocyte antigen, rejection, cardiac allograft vasculopathy, and long-term noncardiac care. Attention is also given to Canadian-specific management strategies including the prioritization of highly sensitized transplant candidates (status 4S) and heart organ allocation algorithms. The focus topics in this position statement highlight the increased complexity of patients who undergo evaluation for heart transplantation as well as improved patient selection, and advances in post-transplantation management and surveillance that have led to better long-term outcomes for heart transplant recipients.


Assuntos
Assistência ao Convalescente/normas , Definição da Elegibilidade , Transplante de Coração/normas , Seleção de Pacientes , Árvores de Decisões , Definição da Elegibilidade/normas , Humanos
3.
J Thorac Cardiovasc Surg ; 159(3): 865-896, 2020 03.
Artigo em Inglês | MEDLINE | ID: mdl-31983522
5.
J Thorac Cardiovasc Surg ; 158(6): 1652-1660.e4, 2019 12.
Artigo em Inglês | MEDLINE | ID: mdl-31353104

RESUMO

BACKGROUND: Accurately predicting cardiac size by other body parameters has long been problematic to determine whether a donor heart will serve a given waitlist candidate, yet hundreds of heart donors are turned down annually for size mismatch. OBJECTIVES: We sought to describe how donor body weight parameters are currently utilized in cardiac transplantation and its influence on waitlist outcomes. METHODS: From the United Network for Organ Sharing database, pediatric (age <18 years) heart transplant candidates were divided into lower quartile, interquartile, and upper quartile categories based on final maximum acceptable donor-candidate weight ratio (DCW), expressed as percentage. Baseline characteristics and waitlist outcomes, including monthly offers/candidate and survival were compared. RESULTS: Overall median DCW was 200% (range, 159%-241%). Patients with congenital heart disease had higher DCW than those with cardiomyopathy (223% vs 203%; P < .001). Number of monthly offers/candidate (5.0, 5.6, and 7.2, respectively; P < .001) increased with quartile of DCW. Posttransplant survival was similar amongst the groups (log-rank P > .05). Subgroup analysis of critically ill children showed a waitlist survival advantage in those listed with a DCW ≥200% (P < .001). CONCLUSIONS: Despite substantial practice variation in acceptable donor weight in pediatric heart transplantation, patients listed with variable DCW had similar posttransplant survival. However, in critically ill patients, higher DCW was associated with greater waitlist survival. Better understanding of the importance of donor weight could reduce practice variability and improve organ use and waitlist outcomes for pediatric cardiac transplant candidates.


Assuntos
Tamanho Corporal , Seleção do Doador/normas , Disparidades em Assistência à Saúde/normas , Transplante de Coração/normas , Padrões de Prática Médica/normas , Doadores de Tecidos/provisão & distribução , Listas de Espera , Adolescente , Fatores Etários , Criança , Pré-Escolar , Tomada de Decisão Clínica , Bases de Dados Factuais , Medicina Baseada em Evidências , Feminino , Nível de Saúde , Transplante de Coração/efeitos adversos , Humanos , Lactente , Recém-Nascido , Masculino , Tamanho do Órgão , Estudos Retrospectivos , Medição de Risco , Fatores de Risco , Estados Unidos
6.
Crit Care Nurse ; 39(2): 45-52, 2019 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-30936130

RESUMO

Transplant cardiologists in our hospital have performed the percutaneously placed axillary-subclavian intra-aortic balloon pump procedure since 2007. This procedure allows patients to mobilize and walk while they wait for a heart transplant, rather than remaining on bed rest as they would with a traditional femoral intra-aortic balloon pump. This procedure has presented challenges to the nursing staff. A 2007 literature search revealed no precedent or published nursing articles on this subject. This article reviews heart failure, medical treatments, complications of bed rest associated with the femoral intra-aortic balloon pump, the nursing challenges and unique problems of caring for patients with percutaneously placed axillary-subclavian intra-aortic balloon pumps, and our solutions for those challenges.


Assuntos
Assistência Ambulatorial/normas , Enfermagem de Cuidados Críticos/normas , Insuficiência Cardíaca/enfermagem , Transplante de Coração/normas , Balão Intra-Aórtico/enfermagem , Guias de Prática Clínica como Assunto , Cuidados Pré-Operatórios/normas , Coração Auxiliar , Humanos
7.
Pediatr Transplant ; 23(4): e13402, 2019 06.
Artigo em Inglês | MEDLINE | ID: mdl-31012250

RESUMO

There is a limited supply of organs for all those who need them for survival. Thus, careful decisions must be made about who is listed for transplant. Studies show that manifesting genetic disease can impact listing eligibility. What has not yet been studied is the impact genetic risks for future disease have on a patient's chance to be listed. Surveys were emailed to 163 pediatric liver, heart, and kidney transplant programs across the United States to elicit views and experiences of key clinicians regarding each program's use of genetic risks (ie, predispositions, positive predictive testing) in listing decisions. Response rate was 42%. Sixty-four percent of programs have required genetic testing for specific indications prior to listing decisions. Sixteen percent have required it without specific indications, suggesting that genetic testing may be used to screen candidates. Six percent have chosen not to list patients with secondary findings or family histories of genetic conditions. In hypothetical scenarios, programs consider cancer predispositions and adult-onset neurological conditions to be relative contraindications to listing (61%, 17%, and 8% depending on scenario), and some consider them absolute contraindications (5% and 3% depending on scenario). Only 3% of programs have formal policies for these scenarios, but all consult genetic specialists at least "sometimes" for results interpretation. Our study reveals that pediatric transplant programs are using future onset genetic risks in listing decisions. As genetic testing is increasingly adopted into pediatric medicine, further study is needed to prevent possible inappropriate use of genetic information from impacting listing eligibility.


Assuntos
Transplante de Órgãos/métodos , Transplante de Órgãos/normas , Seleção de Pacientes , Obtenção de Tecidos e Órgãos/métodos , Obtenção de Tecidos e Órgãos/normas , Listas de Espera , Adulto , Neoplasias da Mama/genética , Criança , Tomada de Decisões , Progressão da Doença , Exoma , Saúde da Família , Feminino , Genes BRCA1 , Genes p53 , Predisposição Genética para Doença , Testes Genéticos , Variação Genética , Transplante de Coração/métodos , Transplante de Coração/normas , Humanos , Doença de Huntington/genética , Internet , Transplante de Rim/métodos , Transplante de Rim/normas , Transplante de Fígado/métodos , Transplante de Fígado/normas , Masculino , Neoplasias Ovarianas/genética , Pediatria , Fatores de Risco , Inquéritos e Questionários , Estados Unidos , Sequenciamento Completo do Genoma
8.
Heart Fail Rev ; 24(2): 237-244, 2019 03.
Artigo em Inglês | MEDLINE | ID: mdl-30302658

RESUMO

Heart failure is a widespread condition in the United States that is predicted to significantly increase in prevalence in the next decade. Many heart failure patients are given a left ventricular assist device (LVAD) while they wait for a heart transplant, while those that are not able to undergo a heart transplant may be given an LVAD permanently. However, past studies have observed a small subset of heart failure patients that recovered cardiac function of their native heart after being placed on an LVAD. As a result, some patients have been able to have their LVAD explanted and no longer needed a heart transplant. In this review, we analyzed the data of 15 studies that observed recovery of cardiac function in LVAD patients in order to investigate the effects that duration of LVAD support has on patient outcomes. From our review, we identified that there may be negative consequences of prolonged duration of mechanical support such as myocardial atrophy and abnormal calcium cycling as well as circumstances that may allow for a longer duration of LVAD support such as in patients using a continuous-flow LVAD, non-ischemic cardiomyopathy patients, and the specific pharmacological therapy.


Assuntos
Insuficiência Cardíaca/fisiopatologia , Coração Auxiliar/efeitos adversos , Coração/fisiopatologia , Recuperação de Função Fisiológica/fisiologia , Adulto , Atrofia/etiologia , Cálcio/metabolismo , Cardiomiopatia Dilatada/complicações , Cardiomiopatia Dilatada/tratamento farmacológico , Cardiomiopatia Dilatada/fisiopatologia , Clembuterol/administração & dosagem , Clembuterol/uso terapêutico , Feminino , Coração/anatomia & histologia , Coração/efeitos dos fármacos , Insuficiência Cardíaca/epidemiologia , Insuficiência Cardíaca/cirurgia , Transplante de Coração/normas , Coração Auxiliar/estatística & dados numéricos , Humanos , Masculino , Pessoa de Meia-Idade , Miocárdio/patologia , Prevalência , Taxa de Sobrevida , Simpatomiméticos/administração & dosagem , Simpatomiméticos/uso terapêutico , Fatores de Tempo , Estados Unidos/epidemiologia , Remodelação Ventricular/fisiologia
10.
Crit Care Clin ; 35(1): 1-9, 2019 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-30447772

RESUMO

Lung transplantation, heart transplantation, and heart-lung transplantation are life-saving treatment options for patients with lung and/or cardiac failure. Evolution in these therapies over the past several decades has led to better outcomes with application to more patients. The complexity and severity of illness of patients in the pretransplant phase has steadily increased, making posttransplant intensive care unit management more difficult. Despite these factors and the pervasive complications of immunosuppressive therapy, outcomes continue to improve.


Assuntos
Enfermagem de Cuidados Críticos/normas , Doença Hepática Terminal/cirurgia , Cardiopatias/cirurgia , Transplante de Coração/enfermagem , Transplante de Coração-Pulmão/enfermagem , Transplante de Pulmão/enfermagem , Guias de Prática Clínica como Assunto , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Transplante de Coração/normas , Transplante de Coração-Pulmão/normas , Humanos , Unidades de Terapia Intensiva/normas , Transplante de Pulmão/normas , Masculino , Pessoa de Meia-Idade
11.
Crit Care Clin ; 35(1): 45-60, 2019 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-30447780

RESUMO

Management of the cardiac transplant recipient includes careful titration of inotropes and vasopressors. Recipient pulmonary hypertension and ventilatory status must be optimized to prevent allograft right ventricular failure. Vasoplegia, coagulopathy, arrhythmias, and renal dysfunction also require careful management to achieve an optimal outcome. Primary graft dysfunction (PGD) can be an ominous problem after cardiac transplantation. Although mild degrees of PGD may be managed medically, mechanical circulatory support with extracorporeal membrane oxygenation or temporary ventricular assist devices may be required. Retransplantation may be necessary in some cases.


Assuntos
Enfermagem de Cuidados Críticos/normas , Insuficiência Cardíaca/cirurgia , Transplante de Coração/enfermagem , Transplante de Coração/normas , Enfermagem Perioperatória/normas , Guias de Prática Clínica como Assunto , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade
12.
Rev Lat Am Enfermagem ; 26: e3054, 2018 Oct 11.
Artigo em Inglês, Português, Espanhol | MEDLINE | ID: mdl-30328977

RESUMO

OBJECTIVE: to verify the association between the prognostic scores and the quality of life of candidates for heart transplantation. METHOD: a descriptive cross-sectional study with a convenience sample of 32 outpatients applying to heart transplantation. The prognosis was rated by the Heart Failure Survival Score (HFSS) and the Seattle Heart Failure Model (SHFM); and the quality of life by the Minnesota Living With Heart Failure Questionnaire (MLHFQ) and the Kansas City Cardiomyopathy Questionnaire (KCCQ). The Pearson correlation test was applied. RESULTS: the correlations found between general quality of life scores and prognostic scores were (HFSS/MLHFQ r = 0.21), (SHFM/MLHFQ r = 0.09), (HFSS/KCCQ r = -0.02), (SHFM/KCCQ r = -0.20). CONCLUSION: the weak correlation between the prognostic and quality of life scores suggests a lack of association between the measures, i.e., worse prognosis does not mean worse quality of life and the same statement is true in the opposite direction.


Assuntos
Transplante de Coração/normas , Seleção de Pacientes , Qualidade de Vida , Inquéritos e Questionários/normas , Adulto , Idoso , Estudos Transversais , Feminino , Transplante de Coração/psicologia , Humanos , Masculino , Pessoa de Meia-Idade , Prognóstico , Reprodutibilidade dos Testes , Índice de Gravidade de Doença
14.
Cardiol Young ; 28(11): 1295-1298, 2018 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-30207263

RESUMO

Advanced medical and surgical treatment of heart failure and management of patients following heart transplantation is an emerging area. Treatment options at various levels are becoming available in an increasing number of countries. This rapidly evolving field involves a complex multi-disciplinary approach with a number of complementary medical and surgical strategies, including pharmacotherapy, structural cardiac interventions, electrophysiological optimisation, mechanical circulatory support, and heart transplantation. Furthermore, the importance of psycho-social support and care of patients and their families cannot be overstated. The aforementioned challenges and dynamics of new developments require guidance for core and advanced medical training in heart failure and transplantation. The Association for European Paediatric and Congenital Cardiology working group "pulmonary hypertension, heart failure and transplantation" has produced this document as an expert consensus statement; however, all recommendations must be considered and applied in the context of the local and national infrastructure and legal regulations.


Assuntos
Cardiologia/educação , Consenso , Educação de Pós-Graduação em Medicina/normas , Insuficiência Cardíaca/congênito , Insuficiência Cardíaca/terapia , Transplante de Coração/educação , Sociedades Médicas , Criança , Europa (Continente) , Transplante de Coração/normas , Humanos
15.
Psychosomatics ; 59(5): 415-440, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30197247

RESUMO

The psychosocial evaluation is well-recognized as an important component of the multifaceted assessment process to determine candidacy for heart transplantation, lung transplantation, and long-term mechanical circulatory support (MCS). However, there is no consensus-based set of recommendations for either the full range of psychosocial domains to be assessed during the evaluation, or the set of processes and procedures to be used to conduct the evaluation, report its findings, and monitor patients' receipt of and response to interventions for any problems identified. This document provides recommendations on both evaluation content and process. It represents a collaborative effort of the International Society for Heart and Lung Transplantation (ISHLT) and the Academy of Psychosomatic Medicine, American Society of Transplantation, International Consortium of Circulatory Assist Clinicians, and Society for Transplant Social Workers. The Nursing, Health Science and Allied Health Council of the ISHLT organized a Writing Committee composed of international experts representing the ISHLT and the collaborating societies. This Committee synthesized expert opinion and conducted a comprehensive literature review to support the psychosocial evaluation content and process recommendations that were developed. The recommendations are intended to dovetail with current ISHLT guidelines and consensus statements for the selection of candidates for cardiothoracic transplantation and MCS implantation. Moreover, the recommendations are designed to promote consistency across programs in the performance of the psychosocial evaluation by proposing a core set of content domains and processes that can be expanded as needed to meet programs' unique needs and goals.


Assuntos
Transplante de Coração/métodos , Coração Auxiliar , Transplante de Pulmão/métodos , Seleção de Pacientes , Adaptação Psicológica , Adulto , Comportamentos Relacionados com a Saúde , Conhecimentos, Atitudes e Prática em Saúde , Transplante de Coração/psicologia , Transplante de Coração/normas , Coração Auxiliar/psicologia , Humanos , Transplante de Pulmão/psicologia , Transplante de Pulmão/normas , Cooperação do Paciente/psicologia , Implantação de Prótese/métodos , Implantação de Prótese/psicologia , Implantação de Prótese/normas
16.
Arch Cardiovasc Dis ; 111(10): 601-612, 2018 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-29903693

RESUMO

Cardiogenic shock (CS) is a major challenge in contemporary cardiology. Despite a better understanding of the pathophysiology of CS, its management has only improved slightly. The prevalence of CS has remained stable over the past decade, but its outcome has seen few improvements, with the 1-month mortality rate still in the range of 40-60%. Inotropes and vasopressors are the first-line therapies for CS, but they are associated with significant hazards, and have well-known deleterious effects. Furthermore, a significant number of patients develop refractory CS with haemodynamic instability, causing critical organ hypoperfusion and/or pulmonary congestion, despite increasing doses of catecholamines. A major change has resulted from the recent advent and availability of potent mechanical circulatory support (MCS) devices. These devices, which ensure sustained blood flow, provide a great and long-awaited opportunity to improve the prognosis of CS. Several efficient MCS devices are now available, including left ventricle-to-aorta circulatory support devices and full pulmonary and circulatory support with venoarterial extracorporeal membrane oxygenation. However, evidence to support their indications, the timing of implantation and the selection of patients and devices is scarce. Because these devices are gaining momentum and are becoming readily available, the "Unité de Soins Intensifs de Cardiologie" group of the French Society of Cardiology aims to propose practical algorithms for the use of these devices, to help intensive care unit and cardiac care unit physicians in this complex area, where evidence is limited.


Assuntos
Síndrome Coronariana Aguda/terapia , Circulação Assistida/normas , Cardiologia/normas , Unidades de Terapia Intensiva/normas , Choque Cardiogênico/terapia , Síndrome Coronariana Aguda/diagnóstico , Síndrome Coronariana Aguda/mortalidade , Síndrome Coronariana Aguda/fisiopatologia , Algoritmos , Circulação Assistida/efeitos adversos , Circulação Assistida/instrumentação , Circulação Assistida/mortalidade , Tomada de Decisão Clínica , Consenso , Técnicas de Apoio para a Decisão , Transplante de Coração/normas , Hemodinâmica , Humanos , Seleção de Pacientes , Recuperação de Função Fisiológica , Fatores de Risco , Choque Cardiogênico/diagnóstico , Choque Cardiogênico/mortalidade , Choque Cardiogênico/fisiopatologia , Tempo para o Tratamento/normas , Resultado do Tratamento , Função Ventricular
17.
Prog Transplant ; 28(1): 36-42, 2018 03.
Artigo em Inglês | MEDLINE | ID: mdl-29592634

RESUMO

INTRODUCTION: Peripheral neuropathy can affect patients with heart failure, though its prevalence is unknown. After heart transplantation, it can influence the postoperative course and quality of life, but screening for neuromuscular disease is not routinely performed. OBJECTIVE: The aim of this study was to identify the factors associated with neuropathy in a population of patients with heart failure who are candidates for heart transplantation. STUDY DESIGN: Data regarding patients' clinical history, including recent hospitalizations, were collected. All patients underwent a complete neurological examination and a neurophysiological protocol including nerve conduction studies and concentric needle electromyography. RESULTS: Thirty-two patients were included in the study, and neuropathy was diagnosed in 10 (31.3%). Neuropathy was associated with the number of admissions ( P = .023; odds ratio [OR]: 1.96) and the total number of days of hospitalization in the year prior to inclusion in the study ( P = .010; OR: 1.03). The majority of hospitalizations occurred in the step-down unit (85%), with acute heart failure the leading cause of admission (42%). CONCLUSIONS: This study shows that neuropathy is frequent in patients with advanced heart failure and that hospitalization for cardiac care, also in the absence of intensive care, is a marker of high risk of neurologic damage. These data can help physicians in selecting and managing candidates for transplantation and can guide decisions on the best immunosuppressive regimen or rehabilitation strategy.


Assuntos
Insuficiência Cardíaca/complicações , Transplante de Coração/normas , Seleção de Pacientes , Doenças do Sistema Nervoso Periférico/complicações , Doenças do Sistema Nervoso Periférico/etiologia , Guias de Prática Clínica como Assunto , Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Fatores de Risco
19.
Arch Cardiovasc Dis ; 111(2): 126-139, 2018 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-29277435

RESUMO

Assessment of potential donors is an essential part of heart transplantation. Despite the shortage of donor hearts, donor heart procurement from brain-dead organ donors remains low in France, which may be explained by the increasing proportion of high-risk donors, as well as the mismatch between donor assessment and the transplant team's expectations. Improving donor and donor heart assessment is essential to improve the low utilization rate of available donor hearts without increasing post-transplant recipient mortality. This document provides information to practitioners involved in brain-dead donor management, evaluation and selection, concerning the place of medical history, electrocardiography, cardiac imaging, biomarkers and haemodynamic and arrhythmia assessment in the characterization of potential heart donors.


Assuntos
Morte Encefálica/diagnóstico , Seleção do Doador/normas , Transplante de Coração/normas , Doadores de Tecidos/provisão & distribução , Biomarcadores/sangue , Morte Encefálica/fisiopatologia , Cateterismo Cardíaco , Técnicas de Imagem Cardíaca , Consenso , Eletrocardiografia , Feminino , França , Nível de Saúde , Transplante de Coração/efeitos adversos , Humanos , Masculino , Registros Médicos , Pessoa de Meia-Idade , Valor Preditivo dos Testes , Medição de Risco , Fatores de Risco
20.
Rev. latinoam. enferm. (Online) ; 26: e3054, 2018. tab, graf
Artigo em Inglês | LILACS, BDENF - Enfermagem | ID: biblio-961196

RESUMO

ABSTRACT Objective: to verify the association between the prognostic scores and the quality of life of candidates for heart transplantation. Method: a descriptive cross-sectional study with a convenience sample of 32 outpatients applying to heart transplantation. The prognosis was rated by the Heart Failure Survival Score (HFSS) and the Seattle Heart Failure Model (SHFM); and the quality of life by the Minnesota Living With Heart Failure Questionnaire (MLHFQ) and the Kansas City Cardiomyopathy Questionnaire (KCCQ). The Pearson correlation test was applied. Results: the correlations found between general quality of life scores and prognostic scores were (HFSS/MLHFQ r = 0.21), (SHFM/MLHFQ r = 0.09), (HFSS/KCCQ r = -0.02), (SHFM/KCCQ r = -0.20). Conclusion: the weak correlation between the prognostic and quality of life scores suggests a lack of association between the measures, i.e., worse prognosis does not mean worse quality of life and the same statement is true in the opposite direction.


RESUMO Objetivo: verificar a associação entre os escores de prognóstico e a qualidade de vida de pacientes candidatos ao Transplante Cardíaco. Método: estudo transversal descritivo, com amostra de conveniência formada por 32 pacientes ambulatoriais candidatos ao transplante cardíaco. O prognóstico foi classificado pelo Heart Failure Survival Score (HFSS) e pelo Seattle Heart Failure Model (SHFM); e a qualidade de vida pelo Minnesota Living With Heart Failure Questionnaire (MLHFQ) e pelo Kansas City Cardiomyopathy Questionnaire (KCCQ). Aplicou-se o teste de correlação de Pearson. Resultados: as correlações encontradas entre os escores gerais dos instrumentos de qualidade de vida e os escores de prognósticos foram (HFSS/MLHFQ r = 0,21), (SHFM/MLHFQ r = 0,09), (HFSS/KCCQ r = -0,02), (SHFM/KCCQ r = -0,20). Conclusão: a correlação fraca entre os escores de prognóstico e de qualidade de vida sugere a não associação entre as medidas, ou seja, pior prognóstico não significa pior qualidade de vida e o mesmo ocorre no sentido inverso.


RESUMEN Objetivo: verificar la asociación entre los puntajes del pronóstico y la calidad de vida de pacientes candidatos al Trasplante Cardíaco. Método: estudio transversal descriptivo, con una muestra de conveniencia formada por 32 pacientes de ambulatorios candidatos al trasplante cardíaco. El pronóstico fue clasificado por el Heart Failure Survival Score (HFSS) y por el Seattle Heart Failure Model (SHFM) y la calidad de vida por el Minnesota Living With Heart Failure Questionnaire (MLHFQ) y por el Kansas City Cardiomyopathy Questionnaire (KCCQ). Se aplicó el test de correlación de Pearson. Resultados: las correlaciones encontradas entre los puntajes generales de los instrumentos de calidad de vida y los puntajes de pronósticos fueron (HFSS/MLHFQ r = 0,21), (SHFM/MLHFQ r = 0,09), (HFSS/KCCQ r = -0,02), (SHFM/KCCQ r = -0,20). Conclusión: la correlación débil entre los puntajes de pronóstico y de calidad de vida sugiere la no asociación entre las medidas, o sea, peor pronóstico no significa peor calidad de vida y el mismo ocurre en el sentido inverso.


Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Idoso , Inquéritos e Questionários/normas , Transplante de Coração/normas , Transplante de Coração/psicologia , Qualidade de Vida , Índice de Gravidade de Doença , Estudos Transversais , Reprodutibilidade dos Testes , Seleção de Pacientes
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA